News

Patients with asthma and allergic bronchopulmonary aspergillosis experienced improvements with dupilumab, according to data presented at the American Thoracic Society International Conference.Quality ...
The main pharmacological interventions for palliation of breathlessness would be opioids, ie, oromorph and benzodiazepines ...
ABPA is an exaggerated immune response that primarily occurs in individuals with asthma or cystic fibrosis. This form of aspergillosis is characterized by airway inflammation, mucus plugging, and ...
Have you noticed squishy floors? Developed mysterious health symptoms? Learn the red flags of a toxic mold problem in your house. How toxic is mold? Any mold that produces mycotoxins—the “myco” refers ...
One study calculated that 2.5% of adults who have asthma also have ABPA, which is approximately 4.8 million people worldwide. Of these 4.8 million people who have ABPA, an estimated 400,000 also ...
One study calculated that 2.5% of adults who have asthma also have ABPA, which is approximately 4.8 million people worldwide.
Future Microbiol. 2014;9(10):1195-1208. 0 Asymptomatic Never diagnosed to have ABPA in the past, presentation with controlled asthma (according to GINA guidelines) and meeting the diagnostic ...
Introduction Current bronchiectasis guidelines advise against the use of inhaled corticosteroids (ICS) except in patients with associated asthma, allergic bronchopulmonary aspergillosis (ABPA) and/or ...
Introduction Current bronchiectasis guidelines advise against the use of inhaled corticosteroids (ICS) except in patients with associated asthma, allergic bronchopulmonary aspergillosis (ABPA) and/or ...
0 Asymptomatic Never diagnosed to have ABPA in the past, presentation with controlled asthma (according to GINA guidelines) and meeting the diagnostic criteria of ABPA (Box 6) 1 Acute Never ...
A male patient in his 20s presented with a cough and a small volume of haemoptysis that lasted a year. He had no other constitutional symptoms and a respiratory examination was suggestive of a ...